Ichthyosis lamellosa and congenital (with preserved transglutaminase activity) Q80.2

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 19.12.2024

Dieser Artikel auf Deutsch

Synonym(s)

Nonbullous congenital lamellar ichthyosis

Definition
This section has been translated automatically.

The family of autosomal recessive lamellar ichthyoses and congenital ichthyosiform erythroderma are rare, autosomal recessive inherited, usually severe (often collodion babies at birth) cornification anomalies that are etiopathogenetically caused by mutations in various genes (see classification below). About 60% of autosmal recessive congenital erythroderma affect this group. The ARCI group of ichthyoses refers to diseases that were previously referred to as ichthyosis congenita.

Classification
This section has been translated automatically.

The family of autosomal recessive lamellarichthyoses (LI)/congenital ichthyosiform erythroderma (CIE) with preserved transglutaminase activity includes the following variations (the percentages given refer to the total group of autosomal recessive congenital ichthyoses - ACRI)

Occurrence/Epidemiology
This section has been translated automatically.

In the USA, the prevalence of ARCI is estimated at 1:200,000-300,000.

Etiopathogenesis
This section has been translated automatically.

ARCI is associated with mutations in several genes, including ABCA12, ALOX12B, ALOXE3, CYP4F22, NIPAL4, TGM1, CERS3, PNPLA1, CASP14, SDR9C7 and SULT2B1 (Esperón-Moldes U et al. (2020). Most of these identified genes are involved in the synthesis of enzymes and transporters involved in the assembly, transport and/or composition of components of the stratum corneum (Kelly EJ et al. 2011).

A TGM1 gene mutation is the most common cause of ARCI and is closely associated with a collodion membrane at birth. Only 8% of ARCI cases are associated with a CYP4F22 mutation, making this mutant extremely rare.

ARCI can present at birth with a shiny, taut membrane consisting of a thickened stratum corneum called a collodion membrane (Traupe H et al. 2014). Although this is a common clinical manifestation of ARCI, patients with a CYP4F22 mutation usually present with erythroderma instead of a collodion membrane (Traupe H et al. 2014). When present, the collodion membrane dries out, ruptures and detaches over several weeks, revealing the underlying ARCI phenotype.

Manifestation
This section has been translated automatically.

From birth

Clinical features
This section has been translated automatically.

Already at birth picture of a very pronounced erythroderma, in the course of the first years of life eutliche regression; it remains in adolescence and adulthood a variably pronounced, but occasionally only discrete, generalized, fine gray-white scaling with pronounced palmo-Plantarkeratosen. All patients show heat intolerance due to reduced sweating. Particular attention should be paid to this in affected infants (collapse states possible).

Histology
This section has been translated automatically.

Nonspecific; exclusion of epidermolytic hyperkeratosis.

Diagnosis
This section has been translated automatically.

Biochemical detection of transglutaminase deficiency in skin frozen sections. Detection of mutations in the various genes.

Therapy
This section has been translated automatically.

See below Ichthyoses.

Progression/forecast
This section has been translated automatically.

The disorders are lifelong, but may show marked improvement in adulthood.

Literature
This section has been translated automatically.

  1. Akiyama M et al. (2003) The clinical spectrum of nonbullous congenital ichthyosiform erythroderma and lamellar ichthyosis. Clin Exp Dermatol 28: 235-240
  2. Dumenigo A et al. (2022) CYP4F22-Related Autosomal Recessive Congenital Ichthyosis: Clinical Presentation. Cureus 14:e22272.
  3. Esperón-Moldes U et al. (2020) Novel CYP4F22 mutations associated with autosomal recessive congenital ichthyosis (ARCI). Study of the CYP4F22 c.1303C>T founder mutation. PLoS One 15:0. doi: 10.1371/journal.pone.0229025.
  4. Hotz A et al. (2018) Mutation update for CYP4F22 variants associated with autosomal recessive congenital ichthyosis. Hum Mutat 39:1305-1313.
  5. Kelly EJ et al. (2011) Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states. Mol Interv11:124-132.
  6. Lefevre C et al. (2006) Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum Molec Genet 15: 767-776
  7. Lugassy J et al. (2008) Rapid detection of homozygous mutations in congenital recessive ichthyosis. Arch Derm Res 300: 81-85.
  8. Ohno Y et al. (2015) Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation. Proc Natl Acad Sci U S A 112:7707-7712.
  9. Sayeb M et al. (2019) A Tunisian family with a novel mutation in the gene CYP4F22 for lamellar ichthyosis and co-occurrence of hearing loss in a child due to mutation in the SLC26A4 gene. Int J Dermatol 58:1439-1443.
  10. Traupe H et al. (2014) Nonsyndromic types of ichthyoses - an update. Dtsch Dermatol Ges. 12:109-121.
  11. Ganemo A et al. (2003) Autosomal recessive congenital ichthyosis in Sweden and Estonia: clinical, genetic and ultrastructural findings in eighty-three patients. Acta Derm Venereol 83: 24-30
  12. Esposito G et al. (2001) Transglutaminase 1 gene mutations in Italian patients with autosomal recessive lamellar ichthyosis. J Invest Dermatol 116: 809-812

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 19.12.2024